In the Line for Scarce Covid Treatments, Immunocompromised Americans Should Go Before the Unvaccinated

Publication Date

1-26-2022

Document Type

Article

Organizational Units

Sturm College of Law

Keywords

COVID, Immunocompromised, Bioethics, Public health

Abstract

At a moment when COVID-19 hospitalizations are high and treatments for the disease scarce, here's an ethical question: Should people who have refused coronavirus vaccines be allowed to compete for treatments with people who are immunocompromised?

We think no. Doing so would be unfair to Americans who remain unprotected by vaccines through no choice of their own.

Copyright Statement / License for Reuse

All Rights Reserved
All Rights Reserved.

Publication Statement

User is responsible for all copyright compliance.

Link to Full Text

Find in Compass


Share

COinS